- Home
- TAOP vs EVOK Comparison
TAOP vs EVOK Comparison
Compare TAOP & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- EVOK
- Stock Information
- Founded
- TAOP 1993
- EVOK 2007
- Country
- TAOP China
- EVOK United States
- Employees
- TAOP N/A
- EVOK N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- EVOK Health Care
- Exchange
- TAOP Nasdaq
- EVOK Nasdaq
- Market Cap
- TAOP 3.6M
- EVOK 4.2M
- IPO Year
- TAOP N/A
- EVOK 2013
- Fundamental
- Price
- TAOP $0.25
- EVOK $2.59
- Analyst Decision
- TAOP
- EVOK
- Analyst Count
- TAOP 0
- EVOK 0
- Target Price
- TAOP N/A
- EVOK N/A
- AVG Volume (30 Days)
- TAOP 169.4K
- EVOK 27.3K
- Earning Date
- TAOP 05-05-2025
- EVOK 03-13-2025
- Dividend Yield
- TAOP N/A
- EVOK N/A
- EPS Growth
- TAOP N/A
- EVOK N/A
- EPS
- TAOP 0.50
- EVOK N/A
- Revenue
- TAOP $42,636,173.00
- EVOK $10,249,415.00
- Revenue This Year
- TAOP N/A
- EVOK $99.03
- Revenue Next Year
- TAOP N/A
- EVOK $60.15
- P/E Ratio
- TAOP $0.40
- EVOK N/A
- Revenue Growth
- TAOP 37.49
- EVOK 97.84
- 52 Week Low
- TAOP $0.23
- EVOK $2.40
- 52 Week High
- TAOP $1.19
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- TAOP 35.78
- EVOK 25.65
- Support Level
- TAOP $0.26
- EVOK $2.66
- Resistance Level
- TAOP $0.27
- EVOK $2.81
- Average True Range (ATR)
- TAOP 0.02
- EVOK 0.31
- MACD
- TAOP -0.00
- EVOK -0.02
- Stochastic Oscillator
- TAOP 16.43
- EVOK 13.35
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.